LEADER 01949nam 2200373 450 001 9910688366303321 005 20230626064129.0 035 $a(CKB)5400000000046040 035 $a(NjHacI)995400000000046040 035 $a(EXLCZ)995400000000046040 100 $a20230626d2020 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aConnective Tissue Disease $ecurrent state of the art /$fedited by Akira Takeda 210 1$aLondon :$cIntechOpen,$d2020. 210 4$dİ2020 215 $a1 online resource (96 pages) 311 $a1-78985-842-9 320 $aIncludes bibliographical references and index. 330 $aConnective tissue diseases (CTDs) comprise a number of systemic autoimmune disorders and related conditions characterized by rheumatic manifestations, production of myriad autoantibodies, and varied immune-mediated organ injury. To achieve the best outcomes for patients, accurate evaluation has become critical, and thus advanced diagnostic and assessment modalities have been developed that have had a revolutionary impact in precise characterization of the disease conditions in CTDs. This book provides an in-depth look at the current state of CTDs, while also presenting an overview that is easily understandable to newcomers to the field. Chapters cover such conditions as rheumatoid arthritis, lupus, systemic sclerosis spectrum diseases, and spondyloarthritis, as well as the importance of physical activity and exercise training in the clinical course of CTDs. 517 $aConnective Tissue Disease 606 $aConnective tissues$xDiseases 615 0$aConnective tissues$xDiseases. 676 $a616.77 702 $aTakeda$b Akira 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910688366303321 996 $aConnective Tissue Disease$92513367 997 $aUNINA